Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA

Blood

Volumn 112, Issue 13, 2008, Pages 5122-5129

  Chu, Charles C ^a,b,c   Catera, Rosa ^a   Hatzi, Katerina ^a   Yan, Xiao Jie ^a   Zhang, Lu ^a   Wang, Xiao Bo ^a   Fales, Henry M ^d   Allen, Steven L ^a,b,e   Kolitz, Jonathan E ^a,b,c   Rai, Kanti R ^a,b,e   Chiorazzi, Nicholas ^a,b,e  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN IIA; UNCLASSIFIED DRUG; CANCER ANTIBODY; MYOSIN IIA;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL STRESS; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; GENE REARRANGEMENT; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; LEUKEMIA CELL; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; WESTERN BLOTTING; ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; CELL CLONE; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; PATHOLOGY; STEREOISOMERISM;

ANTIBODIES, NEOPLASM; ANTIGEN-ANTIBODY COMPLEX; APOPTOSIS; B-LYMPHOCYTES; CELL SURVIVAL; CLONE CELLS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; NONMUSCLE MYOSIN TYPE IIA; STEREOISOMERISM;

EID: 55749091407     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-06-162024     Document Type: Article

References (51)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840-1847.
3. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848-1854.
4. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515-1525.
5. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194:1625-1638.
6. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immuno-globulin mutation genotype in B cell chronic lym-phocytic leukemia. J Exp Med. 2001;194:1639-1647.
7. Damle RN, Ghiotto F, Valetto A, et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood. 2002;99: 4087-4093.
8. Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood. 2003;101: 4952-4957.
9. Ghiotto F, Fais F, Valetto A, et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest. 2004;113:1008-1016.
10. Messmer BT, Albesiano E, Efremov DG, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med. 2004;200:519-525.
11. Widhopf GF 2nd, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood. 2004;104:2499-2504.
12. Murray F, Darzentas N, Hadzidimitriou A, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood. 2008;111:1524-1533.
13. Herve M, Xu K, Ng YS, et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest. 2005;115:1636-1643.
14. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL. GenBank. Nucleic Acids Res. 2008;36:D25-30.
15. Mason JM, Naidu MD, Barcia M, Porti D, Chavan SS, Chu CC. Interleukin-four induced gene-1 (Il4i1) is a leukocyte L-amino acid oxidase with an unusual acidic pH preference and lysosomal localization. J Immunol. 2004;173:4561-4567.
16. Boja ES, Hoodbhoy T, Garfield M, Fales HM. Structural conservation of mouse and rat zona pellucida glycoproteins: probing the native rat zona pellucida proteome by mass spectrometry. Biochemistry. 2005;44:16445-16460.
17. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics Int. 2004;11:36-42.
18. Kovacs M, Toth J, Hetenyi C, Malnasi-Csizmadia A, Sellers JR. Mechanism of blebbistatin inhibition of myosin II. J Biol Chem. 2004;279:35557-35563.
19. Salhia B, Hwang JH, Smith CA, et al. Role of myosin II activity and the regulation of myosin light chain phosphorylation in astrocytomas. Cell Motil Cytoskeleton. 2008;65:12-24.
20. ValsterA, Tran NL, Nakada M, Berens ME, Chan AY, Symons M. Cell migration and invasion assays. Methods. 2005;37:208-215.
21. Conti MA, Adelstein RS. Nonmuscle myosin II moves in new directions. J Cell Sci. 2008;121:11-18.
22. Kato M, Fukuda H, Nonaka T, Imajoh-Ohmi S. Cleavage of nonmuscle myosin heavy chain-A during apoptosis in human Jurkat T cells. J Biochem. 2005;137:157-166.
23. Zhang M, Alicot EM, Chiu I, et al. Identification of the target self-antigens in reperfusion injury. J Exp Med. 2006;203:141-152.
24. Lanemo Myhrinder A, Hellqvist E, Sidorova E, et al. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood. 2008;111:3838-3848.
25. Cunningham MW. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front Biosci. 2003;8[suppl]:533-543.
26. Leon JS, Daniels MD, Toriello KM, Wang K, Engman DM.Acardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect Immun. 2004;72:3410-3417.
27. Lawson CM, O'Donoghue HL, Reed WD. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunology. 1992;75:513-519.
28. Galvin JE, Hemric ME, Ward K, Cunningham MW. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest. 2000;106:217-224.
29. von Muhlen CA, Chan EK, Peebles CL, Imai H, Kiyosawa K, Tan EM. Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus-associated chronic liver diseases. Clin Exp Immunol. 1995;100:67-74.
30. Hatzi K, Catera R, Ferrarini M, et al. B-cell chronic lymphocytic leukemia (B-CLL) cells express antibodies reactive with antigenic epitopes expressed on the surface of common bacteria. Blood. 2006;108:12a.
31. Landgren O, Rapkin JS, Caporaso NE, et al. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood. 2007;109: 2198-2201.
32. Du MQ, Isaccson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol. 2002;3:97-104.
33. Martin T, Duffy SF, Carson DA, Kipps TJ. Evidence for somatic selection of natural autoanti-bodies. J Exp Med. 1992;175:983-991.
34. Lieby P, SoleyA, Knapp AM, et al. Memory B cells producing somatically mutated antiphospho-lipid antibodies are present in healthy individuals. Blood. 2003;102:2459-2465.
35. Martin T, Crouzier R, Weber JC, Kipps TJ, Pasquali JL. Structure-function studies on a poly-reactive (natural) autoantibody: polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain. J Immunol. 1994;152:5988-5996.
36. Meffre E, Salmon JE. Autoantibody selection and production in early human life. J Clin Invest. 2007;117:598-601.
37. Merbl Y, Zucker-Toledano M, Quintana FJ, Cohen IR. Newborn humans manifest autoantibodies to defined self molecules detected by antigen mi-croarray informatics. J Clin Invest. 2007;117:712-718.
38. Laroche-Traineau J, Biard-Piechaczyk M, Jacobin MJ, et al. Analysis of VH and VL genes of a monospecific human anti-myosin antibody produced by a B cell from the primary repertoire. Hum Antibodies. 1999;9:177-188.
39. Peng Y, Kowalewski R, Kim S, Elkon KB. The role of IgM antibodies in the recognition and clearance of apoptotic cells. Mol Immunol. 2005;42: 781-787.
40. Binder CJ, Silverman GJ. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol. 2005;26:385-404.
41. Fu M, Fan PS, Li W, et al. Identification of poly-reactive natural IgM antibody that recognizes late apoptotic cells and promotes phagocytosis of the cells. Apoptosis. 2007;12:355-362.
42. Catera R, Hatzi K, Chu CC, et al. Polyreactive monoclonal antibodies synthesized by some B-CLL cells recognize specific antigens on viable and apoptotic T cells. Blood. 2006;108:796a.
43. Gurrieri C, McGuire P, Zan H, et al. Chronic lym-phocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification. J Exp Med. 2002;196:629-639.
44. Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol. 1997;158:235-246.
45. Nikitin EA, Pivnik AV, Sudarikov AB, et al. A comparison of the forms of chronic lympholeukemia in relation to the mutational status of the genes of the immunoglobulin variable region. Ter Arkh. 2000;72:52-56.
46. Nardini E, Neri F, Vicenzi E, et al. Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patients. Int J Cancer. 2003;107:958-961.
47. Stamatopoulos K, Belessi C, Hadzidimitriou A, et al. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood. 2005;106: 3575-3583.
48. Stamatopoulos K, Belessi C, Moreno C, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood. 2007;109:259-270.
49. Tobin G, Thunberg U, Karlsson K, et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood. 2004;104:2879-2885.
50. Tschumper RC, Geyer SM, Campbell ME, et al. Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients. J Clin Invest. 2008;118:306-315.
51. Giudicelli V, Duroux P, Ginestoux C, et al. IMGT/ LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res. 2006;34:D781-D784.